Inhibition of dipeptidyl peptidase 8/9 impairs preadipocyte differentiation

Ruijun Han, Xinying Wang, William Bachovchin, Zofia Zukowska, John W. Osborn

Research output: Contribution to journalArticlepeer-review

24 Scopus citations


Adipocytes are the primary cells in adipose tissue, and adipocyte dysfunction causes lipodystrophy, obesity and diabetes. The dipeptidyl peptidase (DPP) 4 family includes four enzymes, DPP4, DPP8, DPP9 and fibroblast activation protein (FAP). DPP4 family inhibitors have been used for the treatment of type 2 diabetes patients, but their role in adipocyte formation are poorly understood. Here we demonstrate that the DPP8/9 selective inhibitor 1G244 blocks adipogenesis in preadipocyte 3T3-L1 and 3T3-F422A, while DPP4 and FAP inhibitors have no effect. In addition, knockdown of DPP8 or DPP9 significantly impairs adipocyte differentiation in preadipocytes. We further uncovered that blocking the expression or activities of DPP8 and DPP9 attenuates PPARγ2 induction during preadipocyte differentiation. Addition of PPARγ agonist thiazolidinediones (TZDs), or ectopic expression of PPARγ2, is able to rescue the adipogenic defect caused by DPP8/9 inhibition in preadipocytes. These results indicate the importance of DPP8 and DPP9 on adipogenesis.

Original languageEnglish (US)
Article number12348
JournalScientific reports
StatePublished - Aug 5 2015

Bibliographical note

Funding Information:
The authors thank Dr. Yan Chen, Dr. Alessandro Bartolomucci, Dr. Jana Strakova, Dr. Gufa Lin, Dr. Joanna Kitlinska, Dr. Christopher T Banek and Dr. Ninitha Asirvatham Jeyaraj for their insightful comments and editing. This work was supported by U.S. National Institutes of Health grants R01HL067357 to Z.Z. and J.W.O.


Dive into the research topics of 'Inhibition of dipeptidyl peptidase 8/9 impairs preadipocyte differentiation'. Together they form a unique fingerprint.

Cite this